Here, the authors develop a dual-antigen (preS1-HBsAg) mRNA vaccine that elicits specific immune responses in a mouse model of chronic Hepatitis B virus (HBV) infection, that when combined with IFN-α ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results